Patents by Inventor Stephen G. Swisher

Stephen G. Swisher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AND METHODS FOR THE TREATMENT OF PKR-ASSOCIATED DISEASES
    Publication number: 20220143030
    Abstract: Provided herein are RNA-dependent protein kinase (PKR)-associated compounds for the treatment of PKR-associated disorders including cancer, neurodegenerative diseases, and inflammatory conditions.
    Type: Application
    Filed: February 7, 2020
    Publication date: May 12, 2022
    Applicant: Board of Regents, The University of Texas System
    Inventors: Apar PATAER, Bulent OZPOLAT, Stephen G. SWISHER, Ruping SHAO
  • Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery
    Patent number: 6899870
    Abstract: The present invention generally relates to viral vectors and their use as expression vectors for transforming human cells, both in vitro and in vivo. More particularly, the present invention relates to adenoviral vectors containing propapoptotic genes and their use in cancer therapy.
    Type: Grant
    Filed: March 11, 1999
    Date of Patent: May 31, 2005
    Assignee: Board of Regents, The University of Texas System
    Inventors: Timothy J. McDonnell, Stephen G. Swisher, Bingliang Fang, Elizabeth M. Bruckheimer, Mona G. Sarkiss, Lin Ji, Jack A. Roth